# Scribe Therapeutics

engineered CasX (X-edit) CRISPR platform, partnered with Sanofi on in-vivo editing.


Source: https://cn.bioecon.ru/companies/scribe-therapeutics/
Updated: 2026-07-29

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 2026年7月IPO募资$128.7 million，IPO前另筹得约$150 million | https://endpoints.news/gene-editor-scribe-starts-second-half-ipo-spree-with-129m-listing/, https://medcitynews.com/2026/07/scribe-therapeutics-ipo-crispr-genetic-medicine-pcsk9-ascvd-sctx/, https://www.sec.gov/Archives/edgar/data/1853921/000119312526294804/d21355ds1.htm |
| 融资 | 来自 CIRM 的资助最高约 2570万美元 | https://medcitynews.com/2026/07/scribe-therapeutics-ipo-crispr-genetic-medicine-pcsk9-ascvd-sctx/, https://www.biospace.com/scribe-therapeutics-announces-research-collaboration-with-sanofi-to-accelerate-breakthrough-crispr-based-cell-therapies-for-cancer, https://www.scribetx.com/newsroom/scribe-therapeutics-awarded-more-than-25-million-from-cirm-to-accelerate-additional-crispr-based-gene-editing-therapies-for-cardiometabolic-disease-into-clinical-trials, https://www.sec.gov/Archives/edgar/data/1853921/000119312526294804/d21355ds1.htm |
| 员工人数 | 截至2026年年中为88-89名员工 | https://stockanalysis.com/stocks/sctx/employees/ |
| 总部 | 1150 Marina Village Parkway, Alameda, CA 94501, 美国 | https://medcitynews.com/2026/07/scribe-therapeutics-ipo-crispr-genetic-medicine-pcsk9-ascvd-sctx/, https://www.sec.gov/Archives/edgar/data/1853921/000119312526294804/d21355ds1.htm, https://www.sec.gov/Archives/edgar/data/1853921/000119312526308330/d21355dex1013.htm |
| 监管批准 | 澳大利亚TGA批准STX-1150 1期临床试验（2026年5月） | https://medcitynews.com/2026/07/scribe-therapeutics-ipo-crispr-genetic-medicine-pcsk9-ascvd-sctx/, https://www.sec.gov/Archives/edgar/data/1853921/000119312526294804/d21355ds1.htm |
| 合作 | 与赛诺菲(体内及体外)以及礼来(神经系统/神经肌肉领域)的战略合作 | https://www.biospace.com/scribe-therapeutics-announces-research-collaboration-with-sanofi-to-accelerate-breakthrough-crispr-based-cell-therapies-for-cancer, https://www.sec.gov/Archives/edgar/data/1853921/000119312526294804/d21355ds1.htm, https://www.sec.gov/Archives/edgar/data/1853921/000119312526308330/d21355dex1013.htm |
| 生产基地 | 使用第三方合同生产组织（CMO） | https://www.sec.gov/Archives/edgar/data/1853921/000119312526294804/d21355ds1.htm, https://www.sec.gov/Archives/edgar/data/1853921/000119312526308330/d21355dex1013.htm |

独立来源: biospace.com, endpoints.news, medcitynews.com, scribetx.com, sec.gov, stockanalysis.com

## 技术

- [基因组编辑](https://cn.bioecon.ru/technology/genome-editing/)